Skip to content

Sagenex

Active
Private limited companyfounded 199729 yrs activeChemin des Sauverdias 10, 5000 Namur, BelgiumKBO/BCE: BE 0460.691.897
Summary

Sagenex has been active since 1997 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €14,359 and a net result of €13,637. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 30% of 12386 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisWatch ReportCompare
SagenexActiveChecked score 90/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730Warehousing and support activities for transportation NACE 52310
1 site
Size
€73,820total assets 2025
Staff
1.1 FTE
Equity
€14,359
Profit
€13,637
Turnover not published (abridged schema)
Financial health
90 Excellent Checked score 2025
Bankruptcy chance 12 m
0.2%
Structure
Accounts 11 d early0 of 1 deed read
Why 90- Sector Retail trade (NACE 47)- Equity €14,359 (19.5% of total assets)+ Liquidity: current ratio 1.24, cash €38,355+ Founded in 1997Show the evidence

Checked score

Score 2025
90 / 100
Excellent
Probability in this band: under 0.55%
Better than 68% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Strong
Solvency 44+18
equity 19.5% of total assets
Liquidity 56+6
short-term debt 80.5% · cash 52.0%
Profitability 84+47
return on assets 18.5%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,156 companies)
Last 24 months 11-2024: 0.4% 12-2024: 0.4%● 0.0% vs 11-2024 01-2025: 0.4%▼ -12.4% vs 12-2024 02-2025: 0.4%● 0.0% vs 01-2025 03-2025: 0.4%▼ -1.4% vs 02-2025 04-2025: 0.3%▼ -2.8% vs 03-2025 05-2025: 0.3%▼ -2.6% vs 04-2025 06-2025: 0.3%▼ -3.3% vs 05-2025 07-2025: 0.4%▲ +13.5% vs 06-2025 08-2025: 0.4%▲ +18.1% vs 07-2025 09-2025: 0.4%● 0.0% vs 08-2025 10-2025: 0.5%▲ +5.9% vs 09-2025 11-2025: 0.5%● 0.0% vs 10-2025 12-2025: 0.5%● 0.0% vs 11-2025 01-2026: 0.5%▼ -1.9% vs 12-2025 02-2026: 0.5%▲ +6.6% vs 01-2026 03-2026: 0.5%▼ -0.4% vs 02-2026 04-2026: 0.5%▼ -2.9% vs 03-2026 05-2026: 0.5%▼ -2.6% vs 04-2026 06-2026: 0.4%▼ -3.3% vs 05-2026 07-2026: 0.5%▲ +13.6% vs 06-2026highest value 08-2026: 0.2%▼ -52.3% vs 07-2026 09-2026: 0.2%● 0.0% vs 08-2026 10-2026: 0.2%▼ -2.1% vs 09-2026lowest value
  • Sector Retail trade (NACE 47) raises the probability
  • Liquidity: current ratio 1.24, cash €38,355 lowers the probability
  • Founded in 1997 lowers the probability for this profile
  • Equity €14,359 (19.5% of total assets) raises the probability
Credit up to €1,000 at 30 days acceptable
Liquidity tight (current ratio 1.24 against 1.01 in 2024; short-term debt: 80.5% and cash: 52% of total assets), and 80.5% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 35%, liquidity 62%, profitability 77%, growth against the median 99%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 04-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Sector Retail trade (NACE 47)
In the bankruptcy model this factor raises the probability.
KBO
lowers risk · Liquidity: current ratio 1.24, cash €38,355
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Founded in 1997
In the bankruptcy model this factor lowers the probability for this profile.
KBO
raises risk · Equity €14,359 (19.5% of total assets)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €14,359
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-07-2026, 11 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
11 d early
2024
16 d early
2023
29 d early
2022
31 d late
2021
31 d late
2020
82 d early
2019
126 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 7 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 20 July (5 of the last 5 filed years within 42 days of that day).
Companies Code · seven months
Position in the running window
05-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Back to profitnet €13,637
  3. Annual accounts filedfiscal year 2024 · micro…

Key points

  • Caution: Among the weakest 17% on equitysector median €240,368 · 12,398 companies €14,359 View
  • Active since 1997founded 22-05-1997 29 years View
  • Total assets 20256 fiscal years filed €73,820 View

By topic

Financials

Fiscal year
2025
Total assets
€73,820
Profit
€13,637
Solvency
19.5%
Total assets▼ 7.5%
Net result
20182025
Go to Financials

Timeline

Events
12
Since
2017
Next accounts
by 31-07-2027
  1. 20-07-2026Annual accounts filed
  2. 31-12-2025Back to profit
  3. 15-07-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
22-05-1997
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure